Alkaline-Stable Protein A Chromatography Matrix

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current affinity chromatography matrices with protein A ligands face challenges in alkaline stability during cleaning procedures, limiting the effectiveness of NaOH concentrations and resulting in reduced capacity and efficiency in purifying therapeutic antibodies.

Innovation Solution

Development of a mutant Fc-binding polypeptide with improved alkaline stability by mutating the asparagine residue at position 11 in Staphylococcus Protein A domains to amino acids like glutamic acid, lysine, or tyrosine, and creating multimers of these polypeptides for enhanced binding capacity and stability, coupled with a porous support for use in affinity chromatography.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If high concentrations of NaOH are used for cleaning the affinity matrix, then the removal of contaminants is improved, but the protein A ligand stability deteriorates due to alkaline degradation

Engineering Contradiction:
Improvecontaminant removal effectivenessVSAvoidprotein A ligand stability
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent applies parameter changes by modifying the amino acid sequence of protein A through site-directed mutagenesis. Specifically, asparagine residues at positions 11, 43, and 57 are mutated to amino acids with higher alkaline stability (such as serine, threonine, or amino acids with aromatic side chains). This changes the chemical parameters of the ligand to resist alkaline degradation while maintaining binding functionality, allowing the matrix to withstand higher NaOH concentrations for effective cleaning.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite affinity matrix by combining mutated protein A ligands with support materials optimized for alkaline stability. The composite structure integrates the engineered protein A domains (with enhanced alkaline resistance) onto a stable support matrix, creating a hybrid material that can withstand harsh cleaning conditions. This composite approach allows the system to tolerate higher NaOH concentrations needed for effective contaminant removal.

Inventive Principle:
Principle #40Composite materials

2Productivity

If the affinity matrix is exposed to alkaline cleaning solutions, then the cleaning efficiency is improved, but the binding capacity of the matrix decreases due to ligand instability

Engineering Contradiction:
Improvecleaning efficiencyVSAvoidbinding capacity
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

By changing the amino acid parameters of protein A through mutagenesis, the patent creates ligands with enhanced resistance to alkaline conditions. The mutated residues (particularly at positions 11, 43, and 57) are replaced with amino acids that form more stable structures under alkaline stress, preventing denaturation and capacity loss during cleaning operations.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent implements a multi-step cleaning protocol using progressively increasing NaOH concentrations (e.g., 0.1 M, 0.5 M, 1.0 M). The mutated protein A ligands are designed to withstand this gradient, allowing the system to apply excessive cleaning action (higher concentrations) without suffering the capacity loss that would occur with native protein A. This partial application of increasing stress enables thorough cleaning while preserving binding capacity.

Inventive Principle:
Principle #16Partial or excessive action

3Ease of repair

If repeated cleaning cycles are performed on the affinity matrix, then the matrix regeneration is improved, but the ligand stability deteriorates over time

Engineering Contradiction:
Improvematrix regenerationVSAvoidligand operational lifetime
Core Design Contradiction:
Ease of repairVSDuration of action of stationary object

Solution Approach 1:

The patent applies parameter changes to the protein A sequence to enhance long-term stability. By mutating residues at critical positions (11, 43, 57) to amino acids with higher resistance to alkaline hydrolysis and structural degradation, the ligands maintain their functional integrity through repeated cleaning cycles. This parameter modification extends the operational lifetime of the affinity matrix.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs protective mutations that act as a cushion against cumulative damage from repeated cleaning. The engineered amino acid substitutions preemptively protect the ligand structure from degradation mechanisms that would otherwise accumulate over time. This prior protection allows the matrix to withstand numerous regeneration cycles without significant capacity loss.

Inventive Principle:
Principle #11Beforehand cushioning (Prior cushioning)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The mutant polypeptides exhibit increased alkaline stability and maintained selective binding to immunoglobulins, allowing for high dynamic binding capacity and efficient alkaline cleaning, thereby improving the economic viability of antibody purification processes.

Implementation Method 1

affinity chromatography is used in most cases, as one of the key steps in the purification of these immunoglobulin molecules... proteins capable of specific binding to invariable parts of an immunoglobulin molecule

Methodology Applied
Scientific EffectAffinity binding: Adsorption

Implementation Method 2

separation matrices containing the mutated domains or multimers... comprised of recombinant protein A

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentUS10654887B2Separation matrix
Publication Date: 2020.05.19 CYTIVA BIOPROCESS R&D AB
  • US10654887B2 patent drawing
  • US10654887B2 patent drawing
  • US10654887B2 patent drawing

AI summary

The invention relates to a separation matrix comprising at least 11 mg/ml Fc-binding ligands covalently coupled to a porous support, wherein:a) the ligands comprise multimers of alkali-stabilized Protein A domains, andb) the porous support comprises cross-linked polymer particles having a volume-weighted median diameter (d50,v) of 56-70 micrometers and a dry solids weight of 55-80 mg/ml.